Stock information

Idogen is listed on AktieTorget. See stock information here:
AktieTorget

Ventac Holding (Cyprus) Ltd’s owns 4.3% of the stocks and capital of Idogen after the emission in 2017. The partners of Ventac Holding (Cyprus) operating in Idogen are Lars Hedbys, Dennis Henriksen and Neil Thomas.

Insider tradings

Notification of insider trading exceeding 5000 Euro per year in Idogen should be made to Finansinspektionen and to Idogen at insynsanmalan at idogen dot com.
See Finansinspektionen’s insider registry here:

Finansinspektionen’s insider registry

Idogen develops tolerogenic vaccines – long-acting treatment of autoimmune diseases which currently cannot be cured